Goldsite §¯§Ñ§Ò§à§â §Õ§Ý§ñ §ã§Ñ§Þ§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §ß§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß §ã§Ý§ð§ß§í COVID-19 SARS-Cov-2 (ATK) §à§Õ§à§Ò§â§Ö§ß FDA §Ó §´§Ñ§Ú§Ý§Ñ§ß§Õ§Ö.§¿§ä§à §à§Ù§ß§Ñ§é§Ñ§Ö§ä, §é§ä§à §Ø§Ú§ä§Ö§Ý§Ú §´§Ñ§Ú§Ý§Ñ§ß§Õ§Ñ §ã§Ü§à§â§à §ã§Þ§à§Ô§å§ä §á§â§à§Ó§Ö§â§Ú§ä§î §ã§Ö§Ò§ñ §ß§Ñ COVID-19 §ã §á§à§Þ§à§ë§î§ð Goldsite §ß§Ñ§Ò§à§â§Ñ §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §ã§Ý§ð§ß§ß§í§ç §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó (ATK) §Ó §Õ§à§Þ§Ñ§ê§ß§Ú§ç §å§ã§Ý§à§Ó§Ú§ñ§ç. §¿§ä§Ú §á§â§à§ã§ä§í§Ö §Ó §Ú§ã§á§à§Ý§î§Ù§à§Ó§Ñ§ß§Ú§Ú §ß§Ñ§Ò§à§â§í §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §Þ§à§Ø§ß§à §á§â§Ú§à§Ò§â§Ö§ã§ä§Ú §Ó §â§à§Ù§ß§Ú§é§ß§í§ç §Þ§Ñ§Ô§Ñ§Ù§Ú§ß§Ñ§ç (O).

§¯§Ñ§Ò§à§â Goldstie Covid-19 SARS-CoV-2 Saliva Antigen Kit §Ò§í§Ý §á§â§Ö§Õ§ã§ä§Ñ§Ó§Ý§Ö§ß §Ú §â§Ö§Ü§à§Þ§Ö§ß§Õ§à§Ó§Ñ§ß §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §ê§Ü§à§Ý§î§ß§Ú§Ü§à§Ó §®§Ú§ß§Ú§ã§ä§Ö§â§ã§ä§Ó§à§Þ §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ §¢§à§Ý§Ô§Ñ§â§Ú§Ú §Ó §â§Ñ§Þ§Ü§Ñ§ç §Ü§Ñ§Þ§á§Ñ§ß§Ú§Ú §ã§ä§â§Ñ§ß§í §á§à §Ò§Ö§Ù§à§á§Ñ§ã§ß§à§Þ§å §Ó§à§Ù§Ó§â§Ñ§ë§Ö§ß§Ú§ð §Õ§Ö§ä§Ö§Û §Ó §ê§Ü§à§Ý§å. §°§Õ§à§Ò§â§Ö§ß§à §¯§Ñ§è§Ú§à§ß§Ñ§Ý§î§ß§í§Þ §ä§Ö§Ý§Ö§Ó§Ú§Õ§Ö§ß§Ú§Ö§Þ §Ú §®§Ú§ß§Ú§ã§ä§Ö§â§ã§ä§Ó§à§Þ §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ 25 §à§Ü§ä§ñ§Ò§â§ñ 2021 §Ô. , §¤§à§Ý§Õ§ã§ä§Ú COVID-19 SARS-CoV-2 §³§Ý§ð§ß§Ñ

Goldsite §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó COVID-19 SARS-CoV-2 §à§Õ§à§Ò§â§Ö§ß §®§Ñ§Ý§Ñ§Û§Ù§Ú§Û§ã§Ü§Ú§Þ MDA.§°§è§Ö§ß§Ü§Ñ §ß§Ñ§Ò§à§â§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó Goldsite SARS-CoV-2 §Ò§í§Ý§Ñ §å§ã§á§Ö§ê§ß§à §Ù§Ñ§Ó§Ö§â§ê§Ö§ß§Ñ.§µ§ã§ä§â§à§Û§ã§ä§Ó§à §á§à§Ü§Ñ§Ù§Ñ§Ý§à, §é§ä§à §à§ß§à §ã§á§à§ã§à§Ò§ß§à §à§Ò§ß§Ñ§â§å§Ø§Ú§ä§î §ß§Ñ§Ý§Ú§é§Ú§Ö §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-CoV-2 §Ó §á§â§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§ß§í§ç §à§Ò§â§Ñ§Ù§è§Ñ§ç §ß§à§ã§Ñ §ã §é§å§Ó§ã§ä§Ó§Ú§ä§Ö§Ý§î§ß§à§ã§ä§î§ð 96,7% §Ú §ã§á§Ö§è§Ú§æ§Ú§é§ß§à§ã§ä§î§ð 100%.

Goldsite §¯§Ñ§Ò§à§â §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §ß§Ñ§Ù§Ñ§Ý§î§ß§à§Ô§à §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ COVID-19 SARS-Cov-2 (ATK) §Õ§Ý§ñ §ã§Ñ§Þ§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ ??????????????) §à§Ò§â§Ñ§Ò§Ñ§ä§í§Ó§Ñ§Ö§ä§ã§ñ FDA §Ó §´§Ñ§Ú§Ý§Ñ§ß§Õ§Ö.§·§à§â§à§ê§Ú§Ö §ß§à§Ó§à§ã§ä§Ú §Ù§Ñ§Ü§Ý§ð§é§Ñ§ð§ä§ã§ñ §Ó §ä§à§Þ, §é§ä§à §á§à§ã§Ý§Ö §à§è§Ö§ß§Ü§Ú §Ý§Ñ§Ò§à§â§Ñ§ä§à§â§Ú§ñ §å§á§â§Ñ§Ó§Ý§Ö§ß§Ú§ñ §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ §´§Ñ§Ú§Ý§Ñ§ß§Õ§Ñ §Õ§à§ã§ä§Ú§Ô§Ý§Ñ §ï§Ü§ã§á§Ö§â§ä§ß§à§Ô§à §Ü§à§ß§ã§Ö§ß§ã§å§ã§Ñ §à §ä§à§Þ, §é§ä§à §é§å§Ó§ã§ä§Ó§Ú§ä§Ö§Ý§î§ß§à§ã§ä§î §Ú §ã§á§Ö§è§Ú§æ§Ú§é§ß§à§ã§ä§î

Goldsite §¯§Ñ§Ò§à§â §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §ß§Ñ§Ù§Ñ§Ý§î§ß§à§Ô§à §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ COVID-19 SARS-Cov-2 (ATK) §Õ§Ý§ñ §ã§Ñ§Þ§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §µ§á§â§Ñ§Ó§Ý§Ö§ß§Ú§Ö FDA §Ú §µ§á§â§Ñ§Ó§Ý§Ö§ß§Ú§Ö §á§à §ã§Ñ§ß§Ú§ä§Ñ§â§ß§à§Þ§å §ß§Ñ§Õ§Ù§à§â§å §Ù§Ñ §Ü§Ñ§é§Ö§ã§ä§Ó§à§Þ §á§Ú§ë§Ö§Ó§í§ç §á§â§à§Õ§å§Ü§ä§à§Ó §Ú §Þ§Ö§Õ§Ú§Ü§Ñ§Þ§Ö§ß§ä§à§Ó (FDA) §³§º§¡ §¯§à§Ó§à§ã§ä§Ú §¯§à§Ó§à§ã§ä§Ú §£§Ú§Ü§Ú§ã§Ü§Ý§Ñ§Õ§Ö §Ö§ã§ä§î §Þ§Ö§Õ§Ú§Ñ§æ§Ñ§Û§Ý§í §á§à §ä§Ö§Þ§Ö §°§è§Ö§ß§Ü§Ñ 100% §Ú 96,67% ???????????????????????????????? {[t0] } ??? ????? ??? ???? ? ??? ?????? ??? ??? 100% 97,17% ??? ?.??.???????? ???????? ???????? (???????????) ??? ????? ??? ??????????? ?????? ???? ???? ?????????? ?????????? ????? ????? ??? ??? ??? ??? §®§Ñ§Ü§ã§Ú§Þ§Ñ§Ý§î§ß§Ñ§ñ §ï§æ§æ§Ö§Ü§ä§Ú§Ó§ß§à§ã§ä§î §Ò§í§ã§ä§â§à§Û §Ñ§ä§Ñ§Ü§Ú 100% §¯§Ñ§Ò§à§â §Õ§Ý§ñ §Ò§í§ã§ä§â§à§Ô§à §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §ß§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§í (ATK) Goldsite ??????????? §¯§à§Ó§à§ã§ä§Ú

§¬§Ñ§â§ä§Ñ §Ò§Ö§Ý§à§Ô§à §ã§á§Ú§ã§Ü§Ñ §ß§Ñ§Ò§à§â§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó Goldsite SARS-CoV-2.

§¡§ß§Ñ§Ý§Ú§Ù§Ñ§ä§à§â §Ô§Ý§Ú§Ü§Ú§â§à§Ó§Ñ§ß§ß§à§Ô§à §Ô§Ö§Þ§à§Ô§Ý§à§Ò§Ú§ß§Ñ GSH-60 §Ú §Ñ§ß§Ñ§Ý§Ú§Ù§Ñ§ä§à§â §ã§á§Ö§è§Ú§æ§Ú§é§Ö§ã§Ü§à§Ô§à §Ò§Ö§Ý§Ü§Ñ GPP-100, Omlipo, Aristo §Ú §Þ§ß§à§Ô§Ú§Ö §Õ§â§å§Ô§Ú§Ö §á§Ý§Ñ§ä§æ§à§â§Þ§í §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ HbA1c §á§â§Ú§ß§ñ§Ý§Ú §å§é§Ñ§ã§ä§Ú§Ö §Ó §®§Ö§Ø§Õ§å§ß§Ñ§â§à§Õ§ß§à§Û §æ§Ö§Õ§Ö§â§Ñ§è§Ú§Ú §Ü§Ý§Ú§ß§Ú§é§Ö§ã§Ü§à§Û §ç§Ú§Þ§Ú§Ú §Ú §Ý§Ñ§Ò§à§â§Ñ§ä§à§â§Ú§Û Goldsite. §®§Ö§Õ§Ú§è§Ú§ß§Ñ (IFCC) Hb

Goldsite §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó SARS-CoV-2 §Õ§Ý§ñ COVID-19 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à) §±§â§à§ê§Ö§Ý §à§è§Ö§ß§Ü§å §ï§Ü§ã§á§â§Ö§ã§ã-§Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§é§Ö§ã§Ü§Ú§ç §ä§Ö§ã§ä§à§Ó §ß§Ñ §ã§á§Ö§è§Ú§æ§Ú§é§Ö§ã§Ü§Ú§Ö §Ñ§ß§ä§Ú§Ô§Ö§ß§í SARS-CoV-2 (§å§ã§ä§â§à§Û§ã§ä§Ó§Ñ §ã §Ò§à§Ü§à§Ó§í§Þ §á§à§ä§à§Ü§à§Þ) §Ó §®§Ú§ß§Ú§ã§ä§Ö§â§ã§ä§Ó§Ö §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ §Ú §ã§à§è§Ú§Ñ§Ý§î§ß§à§Ô§à §à§Ò§Ö§ã§á§Ö§é§Ö§ß§Ú§ñ §³§à§Ö§Õ§Ú§ß§Ö§ß§ß§à§Ô§à §¬§à§â§à§Ý§Ö§Ó§ã§ä§Ó§Ñ ( UK DHSC) §Ù§Ñ §à§ä§Ý§Ú§é§ß§å§ð §á§â§à§Ú§Ù§Ó§à§Õ§Ú§ä§Ö§Ý§î§ß§à§ã§ä§î, §Ö§ë§Ö §à§Õ§Ú§ß §â§Ö§Ó§à§Ý§ð§è§Ú§à§ß§ß§í§Û §Þ§à§Þ§Ö§ß§ä §Ù§ß§Ñ§Þ§Ö§ß§å§Ö§ä §ã§à§Ò§à§Û

§³§â§à§é§ß§í§Ö §ß§à§Ó§à§ã§ä§Ú: GOLDSITE SARS-CoV-2 §ß§Ñ§Ù§Ñ§Ý§î§ß§í§Û §Ñ§ß§ä§Ú§Ô§Ö§ß§ß§í§Û §ä§Ö§ã§ä §Õ§Ý§ñ §ã§Ñ§Þ§à§Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à) GOLDSITE SARS-CoV-2 §ß§Ñ§Ù§Ñ§Ý§î§ß§í§Û §Ñ§ß§ä§Ú§Ô§Ö§ß§ß§í§Û §ä§Ö§ã§ä §Õ§Ý§ñ §ã§Ñ§Þ§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à) §à§Õ§à§Ò§â§Ö§ß §Ü §â§Ñ§Ù§Þ§Ö§ë§Ö§ß§Ú§ð §ß§Ñ §â§í§ß§Ü§Ö UNMS SR (§³§Ý§à§Ó§Ñ§Ü§Ú§ñ) §µ§á§â§Ñ§Ó§Ý§Ö§ß§Ú§Ö §ã§ä§Ñ§ß§Õ§Ñ§â§ä§à§Ó, §Þ§Ö§ä§â§à§Ý§à§Ô§Ú§Ú §Ú §Ú§ã§á§í§ä§Ñ§ß§Ú§Û)§²§Ñ§ß§Ö§Ö Goldsite

Goldsite §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó SARS-Cov-2 §Õ§Ý§ñ COVID-19 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à) §à§Õ§à§Ò§â§Ö§ß §ª§ß§ã§ä§Ú§ä§å§ä§à§Þ §±§Ñ§å§Ý§ñ §¿§â§Ý§Ú§ç§Ñ (PEI) §Ó §¤§Ö§â§Þ§Ñ§ß§Ú§Ú §Ù§Ñ §Ö§Ô§à §á§â§Ö§Ó§à§ã§ç§à§Õ§ß§í§Ö §ç§Ñ§â§Ñ§Ü§ä§Ö§â§Ú§ã§ä§Ú§Ü§Ú. §¦§ë§Ö §à§Õ§Ú§ß §â§Ö§Ó§à§Ý§ð§è§Ú§à§ß§ß§í§Û §Þ§à§Þ§Ö§ß§ä §Ù§ß§Ñ§Þ§Ö§ß§å§Ö§ä §ã§à§Ò§à§Û §á§â§Ú§Ù§ß§Ñ§ß§Ú§Ö §Ö§Ô§à §Þ§Ú§â§à§Ó§í§Þ §â§Ö§Ô§å§Ý§Ú§â§å§ð§ë§Ú§Þ §ã§à§à§Ò§ë§Ö§ã§ä§Ó§à§Þ, §Ü§Ñ§Ü §Ó§ã§Ö§Ô§Õ§Ñ §à§ä§Ý§Ú§é§ß§à§Ö §Ü§Ñ§é§Ö§ã§ä§Ó§à.§²§Ñ§ß§Ö§Ö §ß§à§Ó§Ñ§ñ §Ü§à§â§à§ß§Ñ Goldsite